Acute stroke intervention by interventional cardiologists

Catheterization and Cardiovascular Interventions

Volumn 73, Issue 5, 2009, Pages 692-698

  DeVries, James T ^a   White, Christopher J ^a   Collins, Tyrone J ^a   Jenkins, J Stephen ^a   Reilly, John P ^a   Grise, Mark A ^a   McMullan, Paul W ^a   Badawi, Ramy A ^a   Ramee, Stephen R ^a  

^a JOHN OCHSNER HEART AND VASCULAR INSTITUTE   (United States)

Author keywords

Embolization; Peripheral vascular disease; Thrombosis

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE DISEASE; ADULT; ARTERY CATHETERIZATION; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; FEMALE; HEART INFARCTION; HOSPITALIZATION; HUMAN; MALE; MORTALITY; PATIENT SAFETY; RECANALIZATION; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

AGED; ANGIOPLASTY, BALLOON; BRAIN ISCHEMIA; CARDIOLOGY; CEREBRAL ANGIOGRAPHY; COOPERATIVE BEHAVIOR; DISABILITY EVALUATION; EMBOLECTOMY; FEMALE; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; MIDDLE AGED; NEUROLOGY; PATIENT CARE TEAM; PERSONNEL STAFFING AND SCHEDULING; RADIOGRAPHY, INTERVENTIONAL; RADIOLOGY, INTERVENTIONAL; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TREATMENT OUTCOME;

EID: 65549148274     PISSN: 15221946     EISSN: 1522726X     Source Type: Journal    
DOI: 10.1002/ccd.21927     Document Type: Article

References (43)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M, Hong Y. Heart disease and stroke statistics-2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e25-e146.
2. Bozzao L, Fantozzi LM, Bastianello S, Bozzao A, Argentino C, Lenzi GL, Fieschi C. Ischaemic supratentorial stroke: Angiographic findings in patients examined in the very early phase. J Neurol 1989;236:340-342.
3. Fieschi C, Argentino C, Lenzi GL, Sacchetti ML, Toni D, Bozzao L. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 1989; 91:311-321.
4. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995;333:1581-1587.
5. Kleindorfer D, Lindsell CJ, Brass L, Koroshetz W, Broderick JP. National US estimates of recombinant tissue plasminogen activator use. ICD-9 codes substantially underestimate. Stroke 2008;39:924-928.
6. Katzan IL, Furlan AJ, Lloyd LE, Frank JI, Harper DL, Hinchey JA, Hammel JP, Qu A, Sila CA. Use of tissue-type plasminogen activator for acute ischemic stroke: The Cleveland area experience. JAMA 2000;283:1151-1158.
7. Engelstein E, Margulies J, Jeret JS. Lack of t-PA use for acute ischemic stroke in acommunity hospital: High incidence of exclusion criteria. Am J Emerg Med 2000;18:257-260.
8. Kleindorfer DO, Khatri P, Katzan I. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Neurology 2005;65:1844 (author reply 1844).
9. Demaerschalk BM, Yip TR. Economic benefit of increasing utilization of intravenous tissue plasminogen activator for acute ischemic stroke in the United States. Stroke 2005;36:2500-2503.
10. Furlan A, Higashida R, Wechsler L, Gent M, Rowley H, Kase C, Pessin M, Ahuja A, Callahan F, Clark WM, Silver F, Rivera F. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: A randomized controlled trial. Prolyse in acute cerebral thromboembolism. JAMA 1999;282:2003-2011.
11. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, Grubb RL, Higashida RT, Jauch EC, Kidwell C, Lyden PD, Morgenstern LB, Qureshi AI, Rosenwasser RH, Scott PA, Wijdicks EF. Guidelines for the early management of adults with ischemic stroke: A guideline from the American Heart Association/American Stroke Association Stroke Council. Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007;115:e478-e534.
12. Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, Marler JR, Hademenos GJ. Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke 2003;34:1056-1083.
13. Smith WS, Sung G, Starkman S, Saver JL, Kidwell CS, Gobin YP, Lutsep HL, Nesbit GM, Grobelny T, Rymer MM, Silverman IE, Higashida RT, Budzik RF, Marks MP, MERCI Trial Investigators. Safety and efficacy of mechanical embolectomy in acute ischemic stroke: Results of the MERCI trial. Stroke 2005;36:1432-1438.
14. Smith WS, Sung G, Saver J, Budzik R, Duckwiler G, Liebeskind DS, Lutsep HL, Rymer MM, Higashida RT, Starkman S, Gobin YP, Multi MERCI Investigators, Frei D, Grobelny T, Hellinger F, Huddle D, Kidwell C, Koroshetz W, Marks M, Nesbit G, Silverman IE. Mechanical thrombectomy for acute ischemic stroke. Final results of the multi MERCI trial. Stroke 2008;39:1205-1212.
15. Bose A, Henkes H, Alfke K, Reith W, Mayer TE, Berlis A, Branca V, Sit SP. The Penumbra System: A mechanical device for the treatment of acute stroke due to thromboembolism. AJNR Am J Neuroradiol 2008;29:1409-1413.
16. Suzuki S, Saver JL, Scott P, Jahan R, Duckwiler G, Starkman S, Su Y, Kidwell CS. Access to intra-arterial therapies for acute ischemic stroke: An analysis of the US population. AJNR Am J Neuroradiol 2004;25:1802-1806.
17. http://www.strokecenter.org/trials/scales/nihss.html
18. http://ssdi.rootsweb.ancestry.com/cgi-bin/ssdi.cgi
19. http://www.strokecenter.org/trials/scales/rankin.html
20. Ramee SR, Subramanian R, Felberg RA, McKinley KL, Jenkins JS, Collins TJ, Dawson RC, White CJ. Catheter-based treatment for patients with acute ischemic stroke ineligible for intravenous thrombolysis. Stroke 2004;35:e109-e111.
21. Lum C, Stys PK, Hogan MJ, Nguyen TB, Srinivasan A, Goyal M. Acute anterior circulation stroke: Recanalization using clot angioplasty. Can J Neurol Sci 2006;33:217-222.
22. Levy EI, Ecker RD, Horowitz MB, Gupta R, Hanel RA, Sauvageau E, Jovin TG, Guterman LR, Hopkins LN. Stent-assisted intracranial recanalization for acute stroke: Early results. Neurosurgery 2006;58:458-463; discussion 458-463.
23. Lin DD, Gailloud P, Beauchamp NJ, Aldrich EM, Wityk RJ, Murphy KJ. Combined stent placement and thrombolysis in acute vertebrobasilar ischemic stroke. AJNR Am J Neuroradiol 2003;24:1827-1833.
24. Lewandowski CA, Frankel M, Tomsick TA, Broderick J, Frey J, Clark W, Starkman S, Grotta J, Spilker J, Khoury J, Brott T. Combined intravenous and intra-arterial r-TPA versus intra-arterial therapy of acute ischemic stroke: Emergency management of stroke (EMS) bridging trial. Stroke 1999;30:2598-2605.
25. Lee KY, Han SW, Kim SH, Nam HS, Ahn SW, Kim DJ, Seo SH, Kim DI, Heo JH. Early recanalization after intravenous administration of recombinant tissue plasminogen activator as assessed by pre- and post-thrombolytic angiography in acute ischemic stroke patients. Stroke 2007;38:192-193.
26. Wolpert SM, Bruckmann H, Greenlee R, Wechsler L, Pessin MS, del Zoppo GJ. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. The rt-PA acute stroke study group. AJNR Am J Neuroradiol 1993;14:3-13.
27. Rha JH, Saver JL. The impact of recanalization on ischemic stroke outcome: A meta-analysis. Stroke 2007;38:967-973.
28. Flint AC, Duckwiler GR, Budzik RF, Liebeskind DS, Smith WS. Mechanical thrombectomy of intracranial internal carotid occlusion: Pooled results of the MERCI and multi MERCI Part I trials. Stroke 2007;38:1274-1280.
29. Tomsick T, Broderick J, Carrozella J, Khatri P, Hill M, Palesch Y, Khoury J. Revascularization results in the interventional management of stroke II trial. AJNR Am J Neuroradiol 2008;29:582-587.
30. Wechsler LR. Does the merci retriever work? Against Stroke 2006;37:1341-1342; discussion 1342-1343.
31. Schellinger PD, Fiebach JB, Hacke W. Imaging-based decision making in thrombolytic therapy for ischemic stroke: Present status. Stroke 2003;34:575-583.
32. Schaefer PW, Barak ER, Kamalian S, Gharai LR, Schwamm L, Gonzalez RG, Lev MH. Quantitative assessment of core/penumbra mismatch in acute stroke. CT and MR perfusion imaging are strongly correlated when sufficient brain volume is imaged. Stroke 2008;39:2986-2992.
33. White CJ, Cates CU, Cowley MJ, Weiner BH, Carpenter JS, Hopkins LN, Jaff MR, Ramee SR, Rymer MM, Wholey MH. Interventional stroke therapy: Current state of the art and needs assessment. Catheter Cardiovasc Interv 2007;70:471-476.
34. Boden WE, Eagle K, Granger CB. Reperfusion strategies in acute ST-segment elevation myocardial infarction: A comprehensive review of contemporary management options. J Am Coll Cardiol 2007;50:917-929.
35. Marder VJ, Chute DJ, Starkman S, Abolian AM, Kidwell C, Liebeskind D, Ovbiagele B, Vinuela F, Duckwiler G, Jahan R, Vespa PM, Selco S, Rajajee V, Kim D, Sanossian N, Saver JL. Analysis of thrombi retrieved from cerebral arteries of patients with acute ischemic stroke. Stroke 2006;37:2086-2093.
36. Flaherty ML, Haverbusch M, Sekar P, Kissela B, Kleindorfer D, Moomaw CJ, Sauerbeck L, Schneider A, Broderick JP, Woo D. Long-term mortality after intracerebral hemorrhage. Neurology 2006;66:1182-1186.
37. Albers GW, Bates VE, Clark WM, Bell R, Verro P, Hamilton SA. Intravenous tissue-type plasminogen activator for treatment of acute stroke: The standard treatment with alteplase to reverse stroke (STARS) study. JAMA 2000;283:1145-1150.
38. Steinberg BA, Moghbeli N, Buros J, Ruda M, Parkhomenko A, Raju BS, Garcia-Castillo A, Janion M, Nicolau JC, Fox KA, Morrow DA, Gibson CM, Antman EM. Global outcomes of ST-elevation myocardial infarction: Comparisons of the enoxaparin and thrombolysis reperfusion for acute myocardial infarction treatment-thrombolysis in myocardial infarction study 25 (ExTRACT-TIMI 25) registry and trial. Am Heart J 2007; 154:54-61.
39. Kwiatkowski TG, Libman RB, Frankel M, Tilley BC, Morgenstern LB, Lu M, Broderick JP, Lewandowski CA, Marler JR, Levine SR, Brott T. Effects of tissue plasminogen activator for acute ischemic stroke at one year. National institute of neurological disorders and stroke recombinant tissue plasminogen activator stroke study group. N Engl J Med 1999;340:1781-1787.
40. Sheldon WC. Trends in cardiac catheterization laboratories in the United States. Catheter Cardiovasc Interv 2001;53:40-45.
41. Levy EI, Rinaldi MJ, Howington JU, Bendok BR, Kim SH, Harrigan MR, Qureshi AI, Guterman LR, Hopkins N. Should interventional cardiologists treat ischemic strokes? A global perspective. J Invasive Cardiol 2002;14:646-651.
42. IMS Study Investigators. Combined intravenous and intra-arterial recanalization for acute ischemic stroke: The interventional management of stroke study. Stroke 2004;35:904-911.
43. IMS II Trial Investigators. The interventional management of stroke (IMS) II Study. Stroke 2007;38:2127-2135.